Lateral gene transfer (LGT) is essential for generating between-strain genomic recombinants of Chlamydia trachomatis to facilitate the organism's evolution. Because there is no reliable laboratory-based gene transfer system for C. trachomatis, in vitro generation of recombinants from antibiotic-resistant strains is being used to study LGT. However, selection pressures imposed on in vitro recombinants likely affect statistical properties of recombination relative to naturally occurring clinical recombinants, including prevalence at particular loci. We examined multiple loci for 16 in vitro-derived recombinants of ofloxacin-and rifampin-resistant L 1 and D strains, respectively, grown with both antibiotics, and compared these with the same sequenced loci among 11 clinical recombinants. Breakpoints and recombination frequency were examined using phylogenetics, bioinformatics, and statistics. In vitro and clinical isolates clustered perfectly into two groups, without misclassification, using Ward's minimum variance based on breakpoint data. As expected, gyrA (confers ofloxacin resistance) and rpoB (confers rifampin resistance) had significantly more breakpoints among in vitro recombinants than among clinical recombinants (P < 0.0001 and P ؍ 0.02, respectively, using the Wilcoxon rank sum test). Unexpectedly, trpA also had significantly more breakpoints for in vitro recombinants (P < 0.0001). There was also significant selection at other loci. The strongest bias was for ompA in strain D (P ؍ 3.3 ؋ 10 ؊8 ). Our results indicate that the in vitro model differs statistically from natural recombination events. Additional genomic studies are needed to determine the factors responsible for the observed selection biases at unexpected loci and whether these are important for LGT to inform approaches for genetically manipulating C. trachomatis.
Chlamydia trachomatis is the most prevalent sexually transmitted bacterium and the leading cause of preventable blindness in the world. More than 92 million cases are reported annually (42). Infection leads to diseases such as urethritis, cervicitis, pelvic inflammatory disease, infertility, proctitis, reactive arthritis, lymphogranuloma venereum, and trachoma. Over 70% of women and 50% of men who are infected with C. trachomatis are asymptomatic, providing a huge opportunity for unchecked transmission (23, 42). For symptomatic individuals who do seek medical care, diagnostic tests for C. trachomatis, either for initial diagnosis or test of cure, are not always performed, largely due to cost (8). Thus, empirical treatment with antibiotics is common, which may hasten the development of drug resistance. This has already occurred for Chlamydia suis, a species that is closely related to C. trachomatis in which a tetracycline transposon was acquired from other pathogens residing in the guts of pigs (13). C. trachomatis may not be far behind; a number of studies have shown increased MICs of various antibiotics for clinical C. trachomatis isolates or reference strains propagated in tissue...